- ►ahajournals.org M Adiels, SO Olofsson, MR Taskinen, J … - … Thrombosis, and Vascular …, 2008 - Am Heart Assoc •Grundy, SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629–636.
•Barter PJ, Rye KA. Is there a role for fibrates in the management of dyslipidemia in the
metabolic syndrome. Arterioscler ... Cited by 28 - Related articles - All 7 versions
- ►physiology.org D Greco, A Kotronen, J Westerbacka, O … - American Journal of …, 2008 - Am Physiological Soc Despite the high prevalence of nonalcoholic fatty liver disease (NAFLD), little is known of its
pathogenesis based on study of human liver samples. By the use of Affymetrix GeneChips (17,601
genes), we investigated gene ... Cited by 17 - Related articles - BL Direct - All 5 versions
N Stefan, K Kantartzis, HU Haring - Endocrine Reviews, 2008 - Endocrine Soc Type 2 diabetes and cardiovascular disease represent a serious threat to the health of the
population worldwide. Although overall adiposity and particularly visceral adiposity are established
risk factors for these diseases, in ... Cited by 15 - Related articles - All 4 versions
JB Schwimmer, MA Celedon, JE Lavine, R Salem, N … - Gastroenterology, 2009 - Elsevier Overweight children with biopsy-proven NAFLD and overweight children without NAFLD served as
probands. Family members were studied, including the use of magnetic resonance imaging to quantify
liver fat fraction. Fatty liver was ... Cited by 9 - Related articles - All 50 versions
G Musso, R Gambino, M Cassader - Progress in Lipid Research, 2009 - Elsevier Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western
countries and is considered the hepatic manifestation of metabolic syndrome. The hallmark of NAFLD
is hepatic neutral lipid ... Cited by 7 - Related articles - All 2 versions
L Serfaty, J Capeau - Liver Int, 2009 - interscience.wiley.com Epidemiological data indicate a strong risk for development of insulin resistance (IR), and,
ultimately, overt diabetes mellitus (DM) in patients with chronic hepatitis C virus (HCV) infection.
Steatosis, or fatty liver, is ... Cited by 4 - Related articles - All 3 versions
- ►nursing2008.com G Targher, M Chonchol, L Miele, G Zoppini, … - … in Thrombosis & …, 2009 - thieme-connect.com Nonalcoholic fatty liver disease (NAFLD), comprising its whole spectrum of conditions ranging from
simple steatosis to steatohepatitis (nonalcoholic steatohepatitis; NASH) and cirrhosis, is the most
frequent liver disease in developed ... Cited by 2 - Related articles - All 5 versions
SJ Yang, HB IglayReger, HC Kadouh, PF Bodary - Diabetologia, 2009 - Springer Page 1. ARTICLE Inhibition of the chemokine (C–C motif) ligand 2/chemokine (C–C motif) receptor
2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis
and lipoatrophy SJ Yang & HB IglayReger & HC Kadouh & PF Bodary ... Cited by 2 - Related articles - All 2 versions
C Palmer, T Corpuz, M Guirguis, S O'Toole, K Yan, … - British Medical …, 2009 - gut.bmj.com Online First articles must include the digital object identifier (DOIs) and date of initial
publication. establish publication priority; they are indexed by PubMed from initial publication.
Citations to may be posted when ... Cited by 2 - Related articles - All 2 versions
